EXTL2 anticorps (AA 5-110) (AbBy Fluor® 647)

N° du produit ABIN895853

L’anticorps Lapin Polyclonal anti-EXTL2 a été validé pour IF (cc) et IF (p). Il convient pour détecter EXTL2 dans des échantillons de Humain.

Aperçu rapide pour EXTL2 anticorps (AA 5-110) (AbBy Fluor® 647) (ABIN895853)

Antigène: EXTL2 (Exostoses (Multiple)-Like 2 (EXTL2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EXTL2 est conjugé à/à la AbBy Fluor® 647

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-EXTL2 anticorps (AbBy Fluor® 647)

Épitope: AA 5-110

Homologie: Human,Mouse,Rat,Dog,Sheep,Pig,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human EXTL

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur EXTL2

Antigène: EXTL2 (Exostoses (Multiple)-Like 2 (EXTL2))

Autre désignation: EXTL2

Sujet:

Synonyms: Alpha 1 4 N acetylhexosaminyltransferase EXTL2, Alpha GalNAcT EXTL2, Exostoses multiple like 2, Exostoses multiple like 2, Exostosin like 2, EXT L2, EXT related protein 2, EXTL 2, EXTR 2, EXTR2, Glucuronyl galactosyl proteoglycan 4 alpha N acetylglucosaminyltransferase, Multiple exostoses like 2, Processed exostosin like 2, EXTL2_HUMAN.

Background: EXTL2 is a glycosyltransferase required for the biosynthesis of heparan-sulfate and is responsible for the alternating addition of beta-1-4-linked glucuronic acid (GlcA) and alpha-1-4-linked N-acetylglucosamine (GlcNAc) units to nascent heparan sulfate chains.

ID gène: 2134